Dominic Piscitelli
2018 - ANAPTYSBIO
In 2018, Dominic Piscitelli earned a total compensation of $2.1M as Chief Financial Officer at ANAPTYSBIO, a 26% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $146,890 |
|---|---|
| Option Awards | $1,571,275 |
| Salary | $397,000 |
| Other | $540 |
| Total | $2,115,705 |
Piscitelli received $1.6M in option awards, accounting for 74% of the total pay in 2018.
Piscitelli also received $146.9K in non-equity incentive plan, $397K in salary and $540 in other compensation.
Rankings
In 2018, Dominic Piscitelli's compensation ranked 5,438th out of 14,244 executives tracked by ExecPay. In other words, Piscitelli earned more than 61.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,438 out of 14,244 | 62nd |
Division Manufacturing | 2,052 out of 5,765 | 64th |
Major group Chemicals And Allied Products | 750 out of 2,128 | 65th |
Industry group Drugs | 630 out of 1,817 | 65th |
Industry Pharmaceutical Preparations | 485 out of 1,391 | 65th |
Source: SEC filing on April 26, 2019.
Piscitelli's colleagues
We found three more compensation records of executives who worked with Dominic Piscitelli at ANAPTYSBIO in 2018.
News
Oric Pharmaceuticals CEO Jacob Chacko's 2023 pay falls 28% to $3.2M
April 24, 2024
Oric Pharmaceuticals CEO Jacob Chacko's 2022 pay falls 37% to $4.4M
April 26, 2023
Oric Pharmaceuticals CEO Jacob Chacko's 2021 pay rises 19% to $7M
April 27, 2022
Oric Pharmaceuticals CEO Jacob Chacko's 2020 pay jumps 774% to $5.9M
April 26, 2021
ANAPTYSBIO CEO Hamza Suria's 2019 pay jumps 54% to $7.9M
April 27, 2020
ANAPTYSBIO CEO Hamza Suria's 2018 pay jumps 28% to $5.1M
April 26, 2019